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ABSTRACT Data are lacking regarding the impact of visible pigment on rectal
swab diagnostic accuracy. We describe the test characteristics of rectal swabs
with and without pigment in children with gastroenteritis. Between December
2014 and September 2017, children (age, 18 years) with 3 episodes of vomit-
ing and/or diarrhea in a 24-h period and symptoms for 7 days were enrolled
through two pediatric emergency departments and from a province-wide nurs-
ing telephone advice line in Alberta, Canada. Specimens were analyzed by em-
ploying nucleic acid ampliﬁcation panels. The primary outcomes were the sensi-
tivity, speciﬁcity, positive predictive value (PPV), and negative predictive value
(NPV) for the rectal swabs, with stool specimen results being used as the refer-
ence standard. An enteropathogen was detected in 76.0% (1,399/1,841) of the
paired specimens. A total of 54.4% (1,001/1841) of the swabs had visible pig-
ment. The respective enteropathogen detection characteristics of swabs with and
without visible pigment were as follows: 92.2% (95% conﬁdence interval [CI],
90.0%, 94.0%) versus 83.7% (95% CI, 80.5%, 86.4%) for sensitivity, 94.3% (95% CI,
90.5%, 96.6%) versus 91.2% (95% CI, 86.3%, 94.5%) for speciﬁcity, 97.9% (95%
CI, 96.4%, 98.8%) versus 96.5% (95% CI, 94.5%, 97.8%) for PPV, and 80.9% (95%
CI, 76.0%, 85.1%) versus 65.8% (95% CI, 60.0%, 71.1%) for NPV. Processing of
swabs without visible pigment would increase the rate of identiﬁcation of posi-
tive swabs from 50.0% (682/1,365) to 88.3% (1,205/1,365). There is a modest de-
crease in the reliability of a negative test on swabs without evidence of pigment,
but the overall yield is signiﬁcantly greater when they are not excluded from
testing. Hence, rectal swabs without visible feces should not be routinely re-
jected from testing.
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Obtaining stool from children is challenging, particularly in outpatient settings, as asample is frequently not provided by the child during medical visits (1), thereby
prolonging the time to results because of delays in specimen acquisition (2). Handling
of bulk stools also increases exposure risk. Flocked rectal swabs are a potential
alternative that compares favorably with stool specimens (3–6), including when they
are obtained from patients with isolated vomiting (3). Professional society guidelines
endorse rectal swab use in children if timely stool specimens cannot be obtained (7),
but only when visible pigment is noted on the swab (8).
Evidence to support the requirement of visible pigment is sparse. In one study,
approximately 10% of rectal swab specimens received in the microbiology laboratory
were excluded from processing due to the absence of visible pigment (9), and an
unknown proportion were not even submitted from the point of collection for similar
reasons. The absence of visible pigment on a swab is presumed to indicate that the
stool sample on the swab is inadequate, but no published data support the superior
sensitivity of swabs with visible feces. As such, we sought to determine if visible
pigment on a swab affects the diagnostic performance of a multiplex nucleic acid test
for acute gastroenteritis using rectal swabs.
MATERIALS AND METHODS
Study design. This report is a secondary analysis of data collected as part of the Alberta Provincial
Pediatric EnTeric Infection TEam (APPETITE) study (10). From 1 December 2014 to 30 September 2017,
eligible children were consecutively enrolled in pediatric emergency departments (EDs) at the Alberta
Children’s Hospital (Calgary, AB, Canada) and the Stollery Children’s Hospital (Edmonton, AB, Canada).
Eligible children were 18 years of age, had had at least three episodes of vomiting and/or diarrhea in
the preceding 24 h, had had 7 days of symptoms, and submitted paired rectal swab and stool
specimens. Bulk stool specimen results were considered the reference standard. We excluded children
who had been enrolled in this study within the previous 14 days and those presenting with psychiatric
concerns or neutropenia or requiring emergent medical intervention. In a second cohort, children (home
participants) meeting eligibility criteria who had contacted Health Link (Alberta Health Services), a
province-wide nursing triage telephone advice line, were enrolled if the recommendation provided was
to continue care at home.
Informed consent was provided by caregivers; assent was obtained when participants were deemed
sufﬁciently mature to understand study procedures and the potential beneﬁts and harms. The research
ethics boards of the University of Calgary and University of Alberta approved this study.
Specimen acquisition and processing. A standardized data collection form was used to collect
demographic and clinical information. Each participant provided a dry rectal swab (FLOQSwab; Copan
Italia, Brescia, Italy) and a fecal specimen for testing. In the ED, swab specimens were obtained by a study
nurse, who inserted the swab into the rectum and then rotated the swab 360°. For children enrolled
through Health Link, swab and fecal specimens were collected by their caregivers using kits that were
couriered to their home.
The dry rectal swab was transported in a sterile tube (Copan Italia, Brescia, Italy); fecal specimens
were collected in sterile containers (catalog number V302-F; Starplex Scientiﬁc, ON, Canada). If a fecal
specimen was not provided before ED discharge, caregivers were asked to collect the sample at home.
Specimens were stored at room temperature for up to 12 h while awaiting retrieval by a study-funded
courier, who transported the specimens to the laboratory on ice packs.
Upon specimen receipt and before processing, laboratory personnel visually inspected the swabs and
scored them as having either visible fecal material or pigment (i.e., discoloration of the swab) or no
indications of fecal content. After initial processing, stool samples and dry rectal swabs were stored at
80°C until nucleic acid ampliﬁcation testing was performed.
Molecular testing. Nucleic acid extracted from the rectal swabs was tested with a Luminex xTAG
gastrointestinal pathogen panel (GPP; Luminex Molecular Diagnostics, ON, Canada) (6, 11). In addition,
all specimens were tested using an in-house real-time PCR gastroenteritis virus panel (GVP) that detects
adenovirus, astrovirus, norovirus, rotavirus, and sapovirus (12).
Nucleic acid was extracted using a NucliSENS easyMag extractor (bioMérieux, Marcy l’Etoile, France).
Dry fecal swabs were immersed in 750 l of NucliSENS easyMAG lysis buffer and mixed. Three hundred
microliters of the suspension was added to Bertin SK38 soil grinding lysis bead tubes (Luminex Molecular
Diagnostics) along with 10 l of bacteriophage MS2 (Luminex Molecular Diagnostics) to a ﬁnal volume
of 1,000 l. For stool specimens, nucleic acid was extracted from 100 to 150 mg of solid stool or 100 l
of liquid stool. Nucleic acid extracted from the two sample types was eluted to a ﬁnal volume of 70 l
and stored at 80°C until further testing using the GPP and the GVP (12).
A 10-l nucleic acid extract was used in the GPP assay. For the GVP assay, 5 l of nucleic acid extract
was used to generate cDNA by reverse transcription reactions with a ﬁnal volume of 20 l (12). Each
duplex real-time PCR assay targeting norovirus genogroup I (GI) and GII, rotavirus and adenovirus, or
sapovirus and astrovirus contained 3.5 l of cDNA in a ﬁnal volume of 10 l. The reaction was performed
using a 7500 Fast real-time PCR system (Applied Biosystems, Foster City, CA, USA). Cycle threshold (CT)
values of 38 or lower were considered positive.
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Outcomes. The primary outcomes were the sensitivity, speciﬁcity, positive predictive value (PPV),
and negative predictive value (NPV) for the rectal swabs with and without visible pigment for entero-
pathogen detection on either molecular testing platform, with stool specimen test results being used as
the reference standard. Secondary outcomes included the sensitivity, speciﬁcity, PPV, and NPV for rectal
swabs with and without visible pigment based on the testing platform (i.e., GVP and GPP) and pathogen
targets (with combined results from GVP and GPP for viral detection). Other secondary outcomes
included overall enteropathogen positivity and the CT values from the GVP platform for rectal swabs with
and without visible pigment.
Statistical analysis. For the primary outcomes, we derived 95% conﬁdence intervals (CI) using
Wilson’s procedure with a continuity correction (13, 14). We conducted subgroup analyses of the primary
outcomes for (i) the presence of diarrhea or isolated vomiting at the time of specimen collection and (ii)
the specimen collection group (i.e., ED versus home). Isolated vomiting was deﬁned as vomiting without
diarrhea. To evaluate if the interval between specimen collection (i.e., collection of the rectal swab earlier
than collection of stool) affects specimen test characteristics, calculations were repeated with the analysis
restricted to specimens collected within 24 h of each other. Because Clostridioides difﬁcile is identiﬁed in
many asymptomatic young children (15, 16), analyses were also repeated without consideration of C.
difﬁcile detection in children 2 years of age.
Test characteristics for the secondary outcomes were analyzed as described above for the primary
outcomes (see Table S1 in the supplemental material). A multivariable logistic regression assessed the
association between enteropathogen positivity (the dependent variable) and the presence of visible
pigment (the independent variable). The model was adjusted for a priori potential confounders, including
the presence of diarrhea and the collection group (i.e., ED versus home). Model coefﬁcients were
exponentiated to provide estimates of the odds ratio (OR). We compared the cycle threshold values of
positive GVP tests with versus without visible pigment using the Mann-Whitney U test. Two-tailed P
values of 0.05 were considered statistically signiﬁcant. Analyses were conducted using SPSS (version
24.0) software (IBM Corp., Armonk, NY).
RESULTS
Of the 2,847 participants enrolled, 2,530 (88.8%) and 1,941 (67.2%) contributed
rectal swabs and stool specimens, respectively. The 1,841 (64.7%) participants with
paired specimens and documentation of the presence or absence of visible pigment
were included in the analysis (Fig. 1). The participant median age was 17.8 months
(interquartile range [IQR], 10.1, 36.2 months), and the median illness duration at
enrollment was 46 h (IQR, 18, 89 h) (Table 1). The median time interval between illness
onset and specimen acquisition was 60.3 h (IQR, 22.0, 102.5 h) for rectal swabs and
80.4 h (IQR, 42.0, 123.0 h) for stool specimens.
Visible pigment was present on the rectal swab for 54.4% (1,001/1,841) of the
rectal swabs with paired specimens. Rectal swabs collected at home more often had
visible pigment than those submitted in the ED (home, 68.4% [270/395]; ED, 50.6%
[731/1,446]; P 0.001). There was a shorter interval between collection of rectal
swabs with visible pigment and collection of the corresponding stool specimen
than between collection of rectal swabs without visible pigment and collection of
the corresponding stool specimen (0.5 h [IQR, 0, 17.5 h] versus 7.5 h [IQR, 0.3,
24.8 h]; P0.001).
At least one enteropathogen was detected in 76.0% (1,399/1,841) of the paired
specimens. In 160 (11.4%) pairings, only the stool specimen was positive, while in 34
(2.4%), only the rectal swab was positive (see Table S2 in the supplemental material); in
1,205 (86.1%), both were positive.
Primary outcome. Enteropathogen detection sensitivity on swab specimens was
greater when pigment was visible (92.2% [95% CI, 90.0%, 94.0%] versus 83.7% [95% CI,
80.5%, 86.4%]), and speciﬁcity was similar (94.3% [95% CI, 90.5%, 96.6%] versus 91.2%
[95% CI, 86.3%, 94.5%]). Similarly, NPV was higher for swabs with visible pigment (80.9%
[95% CI, 76.0% 85.1%] versus 65.8% [95% CI, 60.0%, 71.1%]) and PPV was similar (97.9%
[95% CI, 96.4%, 98.8%] versus 96.5% [95% CI, 94.5%, 97.8%]) (Table 2). The ﬁnding did
not change signiﬁcantly when C. difﬁcile detection in children 2 years of age was
considered negative (Table S3).
Sensitivity increased for both swabs with and swabs without visible pigment when
children presented with diarrhea (96.5% [95% CI, 94.5%, 97.8%] versus 90.0% [95% CI,
86.8%, 92.6%]). The magnitude of the reduced sensitivity of swabs without visible
pigment was greater among children with isolated vomiting (80.4% [95% CI, 74.1%,
85.5%] versus 66.9% [95% CI, 59.2%, 73.7%]). When restricted to paired specimens
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collected within 24 h, the ﬁndings did not signiﬁcantly change (Table S4). We found a
signiﬁcantly reduced sensitivity of detection of C. difﬁcile (14.5% [95% CI, 2.8, 26.2]) in
swabs without visible pigment (Table 3).
Of the 1,365 participants whose stool specimen contained an enteropathogen,
682 (50.0%) of the corresponding rectal swab specimens had both visible pigment
and a detected pathogen. Inclusion of rectal swabs without visible pigment but
with a pathogen detected (n 523) increased the proportion of participants with
a positive stool specimen identiﬁed by use of a rectal swab to 88.3% (n 1,205)
(Table 2). Of the 34 participants whose rectal swab specimens were positive while
the related bulk stool tested negative, 19 (56%) of the swabs had no visible
pigment.
Secondary outcomes. Differences in sensitivity, speciﬁcity, PPV, and NPV between
swabs with and without visible pigment were consistent on both molecular diagnostic
platforms (Table 4).
Pathogen group analysis demonstrated that swabs with visible pigment had a
greater sensitivity and NPV than swabs without visible pigment and speciﬁcity and PPV
similar to those for swabs without visible pigment for the identiﬁcation of viral
pathogens (sensitivity, 91.3% [95% CI, 88.8%, 93.3%] versus 83.2% [95% CI, 79.8%,
86.1%]; NPV, 96.5% [95% CI, 94.9%, 97.6%] versus 94.3% [95% CI, 92.3%, 95.8%]) and
bacterial pathogens (sensitivity, 83.1% [95% CI, 76.5%, 88.2%] versus 69.6% [95% CI,
61.0%, 77.1%]; NPV, 96.5% [95% CI, 94.9%, 97.6%] versus 94.3% [95% CI, 92.3%, 95.8%])
FIG 1 Study participants and specimens.
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(Table 4). The ﬁnding did not change signiﬁcantly when C. difﬁcile detection in children
2 years of age was considered negative.
Regression analysis (n 2,458) of overall pathogen positivity demonstrated no
difference in enteropathogen detection associated with visible pigment after adjust-
ment for diarrhea presence and sampling group (OR 0.85; 95% CI, 0.71, 1.01; P 0.07)
TABLE 1 Study population characteristics in relation to rectal swabs with visible pigment and rectal swabs without visible pigmentc
Characteristic
Value for individuals providing paired stool and rectal specimens





Median (IQR) age (mo) 17.8 (10.1, 36.2) 17.3 (10.0, 36.0) 18.4 (10.2, 37.5) 0.27
No. (%) of male patients 998 (54.2) 554 (55.3) 444 (52.9) 0.30
No. (%) of patients with the following enrollment location:
ED 1,446 (78.5) 731 (73.0) 715 (85.1) 0.001
Health Link 395 (21.5) 270 (27.0)
No. (%) of patients with:
Antibiotic use in past 60 days 284 (15.4) 159 (15.9) 125 (14.9) 0.60
Vomiting 1,590 (86.4) 861 (86.0) 729 (86.8) 0.54
Diarrhea 1,252 (68.0) 687 (68.6) 565 (67.3) 0.62
Fever 765 (41.6) 401 (40.1) 364 (43.3) 0.25
Median (IQR) symptom duration (h)a 46 (18, 89) 44 (18, 88.8) 48 (18, 90) 0.30
Median (IQR) time (h):
From symptom onset to rectal swab collection 60.3 (22.0, 102.5) 63.3 (22.1, 107.6) 58.3 (21.1, 98.4) 0.24
From symptom onset to stool collection 80.4 (42.0, 123.0) 78.9 (40.1, 122.6) 82.5 (43.6, 125.9) 0.52
Between collection of rectal swab and stool specimens 2.1 (0.02, 21.2) 0.5 (0, 17.5) 7.5 (0.3, 24.8) 0.001
aDuration of vomiting or diarrhea, whichever was greater.
bChi-square test and Mann-Whitney tests were used for comparing categorical and continuous variables between the groups, respectively.
cIQR, interquartile range; ED, emergency department.
TABLE 2 Test characteristics of rectal swabs with or without visible pigment using stool specimen test results as the reference standard
on either a GVP or a Luminex GPPa
Characteristic and pigment
visible on swab
No. of rectal swab specimens












(% [95% CI]) PPV (% [95% CI]) NPV (% [95% CI])
Overall
Yes 682 58 15 246 92.2 (90.0, 94.0) 94.3 (90.5, 96.6) 97.9 (96.4, 98.8) 80.9 (76.0, 85.1)
No 523 102 19 196 83.7 (80.5, 86.4) 91.2 (86.3, 94.5) 96.5 (94.5, 97.8) 65.8 (60.0, 71.1)
Difference 8.5 (4.9, 12.1) 3.1 (1.9, 8.5) 1.4 (0.6, 3.6) 15.2 (7.9, 22.2)
Diarrhea present at enrollment
Yes 522 19 9 137 96.5 (94.5, 97.8) 93.8 (88.3, 96.7) 98.3 (96.7, 99.2) 87.8 (81.4, 92.3)
No 406 45 14 100 90.0 (86.8, 92.6) 87.7 (79.9, 92.9) 96.7 (94.3, 98.1) 69.0 (60.7, 76.2)
Difference 6.5 (3.2, 10.0) 6.1 (1.5, 14.5) 1.6 (0.5, 4.1) 18.9 (9.2, 28.3)
Isolated vomiting at enrollment
Yes 160 39 6 108 80.4 (74.1, 85.5) 94.7 (88.4, 97.8) 96.4 (92.0, 98.5) 73.5 (65.4, 80.3)
No 115 57 5 95 66.9 (59.2, 73.7) 95.0 (88.2, 98.1) 95.8 (90.1, 98.5) 62.5 (54.3, 70.1)
Difference 13.5 (4.2, 22.7) 0.3 (7.3, 7.2) 0.6 (4.6, 6.7) 11.0 (0.09, 21.6)
Swab collected in ED
Yes 468 55 11 197 89.5 (86.5, 91.9) 94.7 (90.5, 97.2) 97.7 (95.8, 98.8) 78.2 (72.5, 83.1)
No 429 93 18 175 82.2 (78.6, 85.3) 90.7 (85.4, 94.2) 96.0 (93.6, 97.5) 65.3 (59.2, 70.9)
Difference 7.3 (2.9, 11.7) 4.0 (1.5, 9.8) 1.7 (0.7, 4.4) 12.9 (4.9, 20.6)
Swab collected at home
Yes 214 3 4 49 98.6 (95.7, 99.6) 92.5 (80.9, 97.6) 98.2 (95.1, 99.4) 94.2 (83.1, 98.5)
No 94 9 1 21 91.3 (83.6, 95.7) 95.5 (75.1, 99.8) 99.0 (93.5, 99.9) 70.0 (50.4, 84.6)
Difference 7.4 (2.1, 15.1) 3.0 (15.3, 18.0) 0.8 (4.0, 4.9) 24.2 (5.9, 44.3)
aAnalyses were stratiﬁed by clinical features. PPV, positive predicted value; NPV, negative predictive value; ED, emergency department.
bThe calculation of sensitivity, speciﬁcity, PPV, and NPV was done using test results based on stool specimens as the reference standard (see Table S3 in the
supplemental material).
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TABLE 3 Test characteristics of rectal swabs with or without visible feces using stool specimens test results as the reference standarda
Organism and feces
visibile on swab
No. of rectal swab specimens












(% [95% CI]) PPV (% [95% CI]) NPV (% [95% CI])
Adenovirus
Yes 147 46 5 803 76.2 (69.5, 82.0) 99.4 (98.6, 99.8) 96.7 (92.1, 98.8) 94.6 (92.8, 96.0)
No 116 56 4 664 67.4 (59.9, 74.4) 99.4 (98.5, 99.8) 96.7 (91.2, 98.9) 92.2 (90.0, 94.0)
Difference 8.7 (0.9, 18.2) -0.02 (1.0, 1.1) 0.04 (4.6, 5.3) 2.4 (0.1, 4.9)
Astrovirus
Yes 24 5 0 972 82.8 (64.2, 94.2) 100 (99.6, 100) 100 (85.8, 100) 99.5 (98.8, 99.8)
No 27 4 1 808 87.1 (70.2, 96.4) 99.9 (99.3, 100) 96.4 (81.7, 99.9) 99.5 (98.7, 99.9)
Difference 4.3 (25.5, 16.5) 0.1 (0.4, 0.8) 3.6 (13.9, 20.2) 0.02 (0.8, 0.9)
Norovirus GI/GII
Yes 225 38 1 737 85.6 (80.7, 89.6) 99.9 (99.2, 100) 99.6 (97.6, 100) 95.1 (93.3, 96.5)
No 158 50 2 630 76.0 (69.6, 81.6) 99.7 (98.9, 100) 98.8 (95.6, 99.8) 92.6 (90.4, 94.5)
Difference 9.6 (2.2, 17.2) 0.2 (0.6, 1.1) 0.8 (1.8, 4.5) 2.5 (0.1, 5.1)
Rotavirus
Yes 184 11 4 802 94.4 (90.1, 97.2) 99.5 (98.7, 99.9) 97.9 (94.6, 99.4) 98.6 (97.6, 99.3)
No 150 20 4 666 88.2 (82.4, 92.7) 99.4 (98.5, 99.8) 97.4 (93.5, 99.3) 97.1 (95.5, 98.2)
Difference 6.1 (0.06, 12.7) 0.1 (0.9, 1.2) 0.5 (3.5, 5.0) 1.6 (0, 3.3)
Sapovirus
Yes 90 7 2 902 92.8 (85.7, 97.0) 99.8 (99.2, 100) 97.8 (92.4, 99.7) 99.2 (98.4, 99.7)
No 60 14 4 762 81.1 (70.3, 89.3) 99.5 (98.7, 99.9) 93.8 (84.8, 98.3) 98.2 (97.0, 99.0)
Difference 11.7 (0.8, 23.5) 0.3 (0.5, 1.2) 4.1 (3.4, 14.0) 1.0 (0.1, 2.4)
Campylobacter spp.
Yes 3 0 0 997 100 (29.2, 100) 100 (99.6, 100) 100 (29.2, 100) 100 (99.6, 100)
No 6 1 0 833 85.7 (42.1, 99.6) 100 (99.6, 100) 100 (54.1, 100) 99.9 (99.3, 100)
Difference 14.3 (56.0, 58.0) 0 (0.5, 0.6) 0 (69.0, 48.3) 0.1 (0.4, 0.8)
Clostridioides difﬁcile
Yes 109 21 29 841 83.8 (76.4, 89.7) 96.7 (95.2, 97.8) 79.0 (71.2, 85.5) 97.6 (96.3, 98.5)
No 68 30 24 718 69.4 (59.3, 78.3) 96.8 (95.2, 97.9) 73.9 (63.7, 82.5) 96.0 (94.3, 97.3)
Difference 14.5 (2.8, 26.2) 0.1 (2.0, 1.8) 5.1 (6.4, 17.2) 1.6 (0.2, 3.5)
Clostridioides difﬁcileb
Yes 6 6 9 979 50.0 (21.1, 78.9) 99.1 (98.3, 99.6) 40.0 (16.3, 67.7) 99.4 (98.7, 99.8)
No 4 10 3 823 28.6 (8.4, 58.1) 99.6 (98.9, 99.9) 57.1 (18.4, 90.1) 98.8 (97.8, 99.4)
Difference 21.4 (19.0, 55.0) 0.6 (1.5, 0.4) 17.1 (55.5, 28.7) 0.6 (0.4, 1.7)
Escherichia coli O157:H7
Yes 4 0 0 996 100 (39.8, 19.4) 100 (99.6, 100) 100 (39.8, 100) 100 (99.6, 100)
No 3 1 0 836 75.0 (19.4, 99.4) 100 (99.6, 100) 100 (29.2, 100) 99.9 (99.3, 100)
Difference 25.0 (39.9, 78.1) 0 (0.5, 0.6) 0 (60.4, 69.0) 0.1 (0.4, 0.8)
Salmonella spp.
Yes 17 3 1 979 85.0 (62.1, 96.8) 99.9 (99.4, 100) 94.4 (72.7, 99.9) 99.7 (99.1, 99.9)
No 9 8 4 819 52.9 (27.8, 77.0) 99.5 (98.8, 99.9) 69.2 (38.6, 90.9) 99.0 (98.1, 99.6)
Difference 32.1 (1.2, 58.9) 0.4 (0.3, 1.2) 25.2 (6.2, 56.0) 0.7 (0.2, 1.7)
Shiga toxin-producing
E. coli (stx1 or stx2)c
Yes 11 3 1 985 78.6 (49.2, 95.3) 99.9 (99.4, 100) 91.7 (61.5, 99.9) 99.7 (99.1, 99.9)
No 6 3 1 830 66.7 (29.9, 92.5) 99.9 (99.3, 100) 85.7 (42.1, 99.6) 99.6 (99.0, 99.9)
Difference 11.9 (26.5, 51.0) 0.02 (0.6, 0.7) 6.0 (28.7, 50.4) 0.06 (0.7, 0.9)
Giardia
Yes 0 3 0 997 0 (0, 70.8) 100 (99.6, 100) NA 99.7 (99.1, 99.9)
No 1 2 0 837 33.3 (0.8, 90.6) 100 (99.6, 100) 100 (2.5, 100) 99.8 (99.1, 100)
Difference 33.3 (87.5, 42.6) 0 (0.5, 0.6) NA 0.06 (0.7, 0.7)
aAnalyses are stratiﬁed by individual pathogens. Pathogens found in 5 samples are not reported. NA, not available.
bC. difﬁcile-positive results for children 2.0 years of age coded as negative.
cOf the 25 Shiga toxin-producing E. coli isolates (stx1 or stx2) GPP positive, 15 were culture negative; positive cultures included E. coli O157:H7 (n 5), E. coli O145:H
nonmotile (n 1), E. coli O26:H11 (n 1), E. coli O76:H19 (n 1), Campylobacter jejuni (n 1), and Shigella ﬂexneri 2a (n 1).
dThe calculation of sensitivity, speciﬁcity, PPV, and NPV was done using test results based on stool specimens as the reference standard.
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(Table S5), reﬂecting the added diagnostic value of processing swabs without visible
pigment. Lastly, rectal swabs without visible pigment had signiﬁcantly higher median
CT values than swabs with visible pigment on quantitative PCR testing for norovirus GII
(24.0 [IQR, 21.4, 28.4] versus 20.5 [IQR, 18.3, 25.5]) and rotavirus (21.2 [IQR, 19.2, 25.1]
versus 19.4 [IQR, 16.7, 22.5]) (Table S6 and Fig. 2).
DISCUSSION
Although swabs without visible pigment had a lower sensitivity and NPV than rectal
swabs with visible pigment, when stool was employed as the reference standard, no
signiﬁcant difference in speciﬁcity or PPV was observed. Although swab specimens
often lack visible pigment, processing them when stool is not available increased the
absolute detection rate of pathogens from 50% to 88%. Although the presence of
pigment is preferred, there are signiﬁcant losses in diagnostic yield if swabs without
pigment are rejected from testing. We suggest that laboratories consider processing
ﬂocked rectal swabs irrespective of feces visibility. Reports should note when pigment
is not observed on the swab and that this may decrease the diagnostic sensitivity of the
test and should prompt recollection of a specimen if it is clinically indicated.
Our ﬁndings call into question the Infectious Diseases Society of America recom-
mendation that rectal swabs without visible feces not be tested by diagnostic micro-
biology laboratories (8), as we found that sensitivity was reduced by only 8.5% and the
NPV was reduced by only by 15.2% in the absence of pigment. Moreover, the reduction
in sensitivity was even less when children presented with diarrhea. While reduced
diagnostic test characteristics are disadvantages, the overall diagnostic performance of
rectal swabs without visible feces (sensitivity, 83.7% to 92.2%; speciﬁcity, 91.2% to
94.3%) is still clinically acceptable and considerably better than not testing a swab
specimen at all. Rejecting swabs without visible pigment would mean that nearly 50%
of rectal swabs would be discarded. While the advantages of testing a swab without
visible pigment include (i) the provision of crucial and timely diagnostic information to
TABLE 4 Test characteristics of rectal swabs with or without visible pigment using stool specimens test results as the reference standarda
Test or organism and
pigment visibile on swab
No. of rectal swab specimens












(% [95% CI]) PPV (% [95% CI]) NPV (% [95% CI])
GVP
Yes 608 59 4 330 91.2 (88.7, 93.1) 98.8 (96.8, 99.6) 99.4 (98.2, 99.8) 84.8 (80.8, 88.2)
No 473 95 12 260 83.3 (79.9, 86.2) 95.6 (92.2, 97.6) 97.5 (95.6, 98.7) 73.2 (68.3, 77.7)
Difference 7.9 (4.1, 11.8) 3.2 (0.4, 6.7) 1.8 (0.2, 3.8) 11.6 (5.6, 17.6)
Luminex GPP
Yes 527 54 25 394 90.7 (88.0, 92.9) 94.0 (91.2, 96.0) 95.5 (93.3, 97.0) 88.0 (84.5, 90.8)
No 412 84 20 324 83.1 (79.4, 86.2) 94.2 (91.0, 96.3) 95.4 (92.8, 97.1) 79.4 (75.1, 83.2)
Difference 7.6 (3.5, 11.9) 0.2 (3.7, 3.6) 0.1 (2.7, 3.1) 8.5 (3.4, 13.7)
Virus
Yes 609 58 6 328 91.3 (88.8, 93.3) 98.2 (95.9, 99.3) 99.0 (97.8, 99.6) 85.0 (80.9, 88.3)
No 474 96 12 258 83.2 (79.8, 86.1) 95.6 (92.3, 97.6) 97.5 (95.6, 98.7) 72.9 (67.9, 77.4)
Difference 8.2 (4.3, 12.1) 2.7 (0.4, 6.2) 1.5 (0.2, 3.5) 12.1 (6.0, 18.1)
Bacteria
Yes 143 29 30 798 83.1 (76.5, 88.2) 96.4 (94.8, 97.5) 82.7 (76.0, 87.8) 96.5 (94.9, 97.6)
No 94 41 27 678 69.6 (61.0, 77.1) 96.2 (94.4, 97.4) 77.7 (69.0, 84.5) 94.3 (92.3, 95.8)
Difference 13.5 (3.5, 23.5) 0.2 (1.8, 2.3) 5.0 (4.6, 15.1) 2.2 (0.01, 4.5)
Bacteriac
Yes 41 14 11 934 74.5 (61.0, 85.3) 98.8 (97.9, 99.4) 78.8 (65.3, 88.9) 98.5 (97.5, 99.2)
No 29 22 7 782 56.9 (42.2, 70.7) 99.1 (98.2, 99.6) 80.6 (64.0, 91.8) 97.3 (95.9, 98.3)
Difference 17.7 (1.6, 35.5) 0.3 (1.4, 0.9) 1.7 (19.2, 17.9) 1.3 (0.2, 2.8)
aAnalyses were stratiﬁed by gastrointestinal virus panel, Luminex gastrointestinal pathogen panel, virus, and bacterium. PPV, positive predicted value; NPV, negative
predictive value.
bThe calculation of sensitivity, speciﬁcity, PPV, and NPV was done using test results based on stool specimens as the reference standard (see Table S1 in the
supplemental material).
cC. difﬁcile-positive results for children 2.0 years of age coded as negative.
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guide therapy and public health strategy and (ii) child and care provider avoidance of
the nuisance and potential risk of specimen collection at home, these beneﬁts need to
be considered in the context of the potential need to retest, which carries with it
ﬁnancial implications. Accepting swabs without pigment may lower the overall quality
of rectal swab submissions, but we consider this unlikely for several reasons. First, the
swabs analyzed for this study were collected for research purposes by nonresearch
personnel (i.e., bedside nurses and caregivers); thus, there was little extrinsic motivation
to ensure that there was pigment on the swab. Second, the procedure is simple and
standardized. The swabs have a ﬂange indicating the desired depth of insertion; there
is little that one can do to get a better specimen. Lastly, caregiver collection at home
(i.e., by untrained individuals) is as good as or better than collection by medical
professionals at yielding a pathogen (3).
The lower sensitivity of rectal swabs when pigment is not visible likely reﬂects the
reduced amount of fecal material extracted for testing and, thus, a lower pathogen load
following nucleic acid extraction (12, 17). This hypothesis is supported by the higher CT
values among positive rectal swabs without visible fecal material and our ﬁnding that the
magnitude of the reduced detection sensitivity was greater among children with isolated
vomiting. Our ﬁndings were stable across the two collection groups and the two testing
platforms, suggesting that results are related to the quality of the specimen. The possibility
exists that the diagnostic yield of swabs without visible feces could be increased by
modifying nucleic acid extraction steps and innovations in detection technologies, as has
been accomplished on buccal swabs obtained for forensic purposes (18).
A possible explanation for the overall greater reduction in the sensitivity among
rectal swabs without visible pigment to detect bacteria than to detect viruses was the
high rate of detection of C. difﬁcile, which was detected in 2.8% more swabs with
pigment visible than in those without visible pigment. As young children are often
colonized with C. difﬁcile (15, 19) with low pathogen loads, the C. difﬁcile density might
more often be below the detection limit in swabs without visible feces. This hypothesis
is supported by evidence that among toxin-positive C. difﬁcile-infected patients, toxin
concentrations are signiﬁcantly higher and CT values are signiﬁcantly lower than those
among carriers (20) and by our ﬁndings of the signiﬁcantly reduced sensitivity of rectal
swabs without pigment to detect C. difﬁcile.
FIG 2 Box plots of real-time PCR cycle threshold (CT) values from rectal swab specimens with versus without visible
pigment that were positive for a given pathogen. Generic adenovirus includes non-type 40/41.
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We acknowledge a number of study limitations. First, we did not assess the impact of
rectal swabs without visible pigment on the sensitivity of bacterial culture. However, CT
values have been demonstrated to relate to culture yield, so the results are likely transfer-
able (21). Second, even though we assessed two molecular testing panels, alternative
commercially available systems may have different sensitivity thresholds. Nonetheless, the
similarity of our ﬁndings between the two panels studied suggests that our results might
be generalizable to other test methods. Additionally, there were few bacterial and parasitic
pathogens identiﬁed in this cohort, so more evidence regarding the use of rectal swabs
without visible pigment for the detection of such pathogens and in cohorts with different
pathogen distributions is needed (22). Also, a signiﬁcant number of participants did not
submit stool specimens and, thus, were excluded from the primary analysis; however,
regression analysis included all tested rectal swab specimens, and it did not ﬁnd a
signiﬁcant difference between the rectal swab groups.
In conclusion, if an alternate specimen is unavailable, we propose that rectal swabs
without visible pigment be tested. In the event of a negative result, when clinically
indicated, testing of a subsequent stool specimen or a repeat rectal swab could be
considered. We suggest that laboratories comment on the visibility of pigment and test
performance when reporting results from rectal swabs in order to help clinicians best
interpret the results and determine if there is a need for repeat testing. Unfortunately,
in our cohort there were few bacterial and parasitic pathogens; thus, additional
evidence is needed to guide testing in children where such pathogens are common.
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